Patents by Inventor Lai-Ming YUNG

Lai-Ming YUNG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS RELATING TO TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
    Publication number: 20210322548
    Abstract: The technology described herein is directed to methods and compositions for the treatment of hypertension, e.g. pulmonary arterial hypertension, relating to inhibition of TGF?1, TGF?3, and/or GDF-15.
    Type: Application
    Filed: April 26, 2021
    Publication date: October 21, 2021
    Applicant: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
    Inventors: Lai-Ming YUNG, Paul B. YU
  • Methods using GDF-15 antibodies for treatment of pulmonary arterial hypertension
    Patent number: 11027014
    Abstract: The technology described herein is directed to methods and compositions for the treatment of hypertension, e.g. pulmonary arterial hypertension, relating to inhibition of TGF?1, TGF?3, and/or GDF-15.
    Type: Grant
    Filed: January 29, 2019
    Date of Patent: June 8, 2021
    Assignee: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
    Inventors: Lai-Ming Yung, Paul B. Yu
  • METHODS AND COMPOSITIONS RELATING TO TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
    Publication number: 20190365857
    Abstract: The technology described herein is directed to methods and compositions for the treatment of hypertension, e.g. pulmonary arterial hypertension, relating to inhibition of TGF?1, TGF?3, and/or GDF-15.
    Type: Application
    Filed: January 29, 2019
    Publication date: December 5, 2019
    Applicant: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
    Inventors: Lai-Ming Yung, Paul B. Yu
  • METHODS AND COMPOSITIONS RELATING TO TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
    Publication number: 20170202918
    Abstract: The technology described herein is directed to methods and compositions for the treatment of hypertension, e.g. pulmonary arterial hypertension, relating to inhibition of TGF?1, TGF?3, and/or GDF-15.
    Type: Application
    Filed: August 3, 2015
    Publication date: July 20, 2017
    Applicant: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
    Inventors: Lai-Ming YUNG, Paul B. YU